-+ 0.00%
-+ 0.00%
-+ 0.00%

Zevra Therapeutics CMO Adrian Quartel to step down July 3 for personal reasons

PUBT·06/11/2026 12:31:28
Listen to the news
Zevra Therapeutics CMO Adrian Quartel to step down July 3 for personal reasons
  • Zevra Therapeutics CMO Adrian Quartel will step down for personal reasons, effective July 3, 2026.
  • Quartel will stay on as a consultant through Dec. 31, 2026 while a successor search runs.
  • Leadership transition comes with arimoclomol’s marketing application under review in Europe; Zevra also continues a Phase 3 celiprolol trial.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zevra Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606110830PRIMZONEFULLFEED9735290) on June 11, 2026, and is solely responsible for the information contained therein.